Loading clinical trials...
Loading clinical trials...
The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sherief Abd-Elsalam
NCT03214679 · Hepatitis C, People Who Inject Drugs, and more
NCT02102451 · Hepatitis C, HIV, and more
NCT03499639 · End-stage Renal Disease, HCV Coinfection
NCT03145753 · HIV Infection, HCV Coinfection
NCT01557998 · HIV Infection, HCV Coinfection
Sherief Abd-Elsalam
Tanta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions